Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1987 1
1988 1
1990 3
1991 2
1992 2
1993 4
1994 3
1995 1
1996 1
1997 6
1998 3
1999 5
2000 12
2001 14
2002 9
2003 14
2004 14
2005 12
2006 16
2007 24
2008 17
2009 24
2010 23
2011 20
2012 22
2013 33
2014 33
2015 38
2016 31
2017 25
2018 33
2019 29
2020 23
2021 35
2022 32
2023 23
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

526 results

Results by year

Filters applied: . Clear all
Page 1
Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease.
Thaler A, Livne V, Rubinstein E, Omer N, Faust-Socher A, Cohen B, Giladi N, Shirvan JC, Cedarbaum JM, Gana-Weisz M, Goldstein O, Orr-Urtreger A, Alcalay RN, Mirelman A. Thaler A, et al. Among authors: giladi n. Parkinsonism Relat Disord. 2024 Apr 16;123:106970. doi: 10.1016/j.parkreldis.2024.106970. Online ahead of print. Parkinsonism Relat Disord. 2024. PMID: 38691978
Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6-Item Score.
Fanciulli A, Stankovic I, Avraham O, Jecmenica Lukic M, Ezra A, Leys F, Goebel G, Krismer F, Petrovic I, Svetel M, Seppi K, Kostic V, Giladi N, Poewe W, Wenning GK, Gurevich T. Fanciulli A, et al. Among authors: giladi n. Mov Disord Clin Pract. 2024 Apr 24. doi: 10.1002/mdc3.14048. Online ahead of print. Mov Disord Clin Pract. 2024. PMID: 38659282
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial.
Espay AJ, Stocchi F, Pahwa R, Albanese A, Ellenbogen A, Ferreira JJ, Giladi N, Gurevich T, Hassin-Baer S, Hernandez-Vara J, Isaacson SH, Kieburtz K, LeWitt PA, Lopez-Manzanares L, Olanow CW, Poewe W, Sarva H, Yardeni T, Adar L, Salin L, Lopes N, Sasson N, Case R, Rascol O; BouNDless Study Group. Espay AJ, et al. Among authors: giladi n. Lancet Neurol. 2024 May;23(5):465-476. doi: 10.1016/S1474-4422(24)00052-8. Epub 2024 Mar 15. Lancet Neurol. 2024. PMID: 38499015 Clinical Trial.
Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device.
Kirk C, Küderle A, Micó-Amigo ME, Bonci T, Paraschiv-Ionescu A, Ullrich M, Soltani A, Gazit E, Salis F, Alcock L, Aminian K, Becker C, Bertuletti S, Brown P, Buckley E, Cantu A, Carsin AE, Caruso M, Caulfield B, Cereatti A, Chiari L, D'Ascanio I, Garcia-Aymerich J, Hansen C, Hausdorff JM, Hiden H, Hume E, Keogh A, Kluge F, Koch S, Maetzler W, Megaritis D, Mueller A, Niessen M, Palmerini L, Schwickert L, Scott K, Sharrack B, Sillén H, Singleton D, Vereijken B, Vogiatzis I, Yarnall AJ, Rochester L, Mazzà C, Eskofier BM, Del Din S; Mobilise-D consortium. Kirk C, et al. Sci Rep. 2024 Jan 19;14(1):1754. doi: 10.1038/s41598-024-51766-5. Sci Rep. 2024. PMID: 38243008 Free PMC article.
Digital Mobility Measures: A Window into Real-World Severity and Progression of Parkinson's Disease.
Mirelman A, Volkov J, Salomon A, Gazit E, Nieuwboer A, Rochester L, Del Din S, Avanzino L, Pelosin E, Bloem BR, Della Croce U, Cereatti A, Thaler A, Roggen D, Mazza C, Shirvan J, Cedarbaum JM, Giladi N, Hausdorff JM. Mirelman A, et al. Among authors: giladi n. Mov Disord. 2024 Feb;39(2):328-338. doi: 10.1002/mds.29689. Epub 2023 Dec 27. Mov Disord. 2024. PMID: 38151859
526 results